1 | 2017 | Francisco Urbina | Clinical variants of pityriasis rosea | World J Clin Cases |
2 | 2022 | Graham Litchman | Pityriasis Rosea | StatPearls Publishing |
3 | 2016 | Francesco Drago | Pityriasis Rosea: A Comprehensive Classification | Dermatology |
4 | 2016 | Khushbu Mahajan | Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects | Indian J Dermatol. |
5 | 2018 | Francesco Drago | Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them? | JAAD Case Rep. |
6 | 2019 | Shuqin Wang | Subsets of T lymphocytes in the lesional skin of pityriasis rosea | An Bras Dermatol. |
7 | 2019 | Serkan Demirkan | Does influenza subtype H1N1 have a place in the etiology of pityriasis rosea? | Postepy Dermatol Alergol. |
8 | 2015 | Vijayeeta Jairath | Narrowband UVB phototherapy in pityriasis rosea | Indian Dermatol Online J. |
9 | 2016 | Mary Thomas | Salute sign: A nonambiguous histopathological sign in pityriasis rosea | Indian Dermatol Online J. |
10 | 2017 | Mostafa Abou El-Ela | Higher Expression of Toll-like Receptors 3, 7, 8, and 9 in Pityriasis Rosea | J Pathol Transl Med. |
11 | 2014 | Ming Zeng | Decreased Serum Level of Interferon-γ in Patients with Pityriasis Rosea | Ann Dermatol. |
12 | 2015 | Francesco Drago | The Role of Cytokines, Chemokines, and Growth Factors in the Pathogenesis of Pityriasis Rosea | Mediators Inflamm. |